Medtronic (MDT) Tops Q1 EPS by 1c; Offers FY23 EPS Guidance
Tweet
Share
E-mail
Get Alerts MDT Hot Sheet
Price: $88.64 --0%
EPS Growth %: -2.2%
Financial Fact:
Research and development expense: 373M
Today's EPS Names:
OCCI, PMCB, BRID, More
EPS Growth %: -2.2%
Financial Fact:
Research and development expense: 373M
Today's EPS Names:
OCCI, PMCB, BRID, More
Join SI Premium – FREE
Medtronic (NYSE: MDT) reported Q1 EPS of $1.13, $0.01 better than the analyst estimate of $1.12. Revenue for the quarter came in at $7.4 billion versus the consensus estimate of $7.22 billion.
GUIDANCE:
Medtronic sees FY2023 EPS of $5.53-$5.65, versus the consensus of $5.56.
For earnings history and earnings-related data on Medtronic (MDT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nvidia’s AI dominance funds historic $150 billion buyback
- Par Pacific names former Valero executive as refining and logistics chief
- Tigress Financial Partners Reiterates Buy Rating on Royal Caribbean Cruises (RCL)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
